Abstract
The success of deep brain stimulation (DBS) therapy in Parkinson’s disease (PD), whether the target is subthalamic nucleus (STN), globus pallidus interna (GPi), or ventral intermediate thalamus (VIM), starts prior to DBS surgery. The route to best outcomes is based on the proper screening and patient selection, followed by identifying expected clinical benefits and setting the stage with the patient for realistic expectations for goals of DBS therapy. Important information to obtain prior to proceeding with DBS therapy include: Presence of tremor and response to PD medication; Amount (hours/minutes) and severity of medication off time with respect to doses of medication, and specific motor symptoms (tremor, rigidity, bradykinesia), with localization to side and part of the body; History and details of gait changes with medication wearing off, or if present at peak, response to medications; Dyskinesia as it relates to medications: peak effect, presence when medication worn off (such as upon awakening, prior to first morning dose of PD medications), or biphasic with respect to medication onset of action and wearing off; Motor score in relationship to best response to medication off/on in a person experiencing motor fluctuations; History of levodopa intolerance. These same issues are often useful to reassess at the first visit after DBS therapy has been initiated and kept in mind subsequently, to help identify potential for further improvement with adjustments in DBS parameters and help achieve stimulation optimization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rizzone M, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: effects of variation in stimulation parameters. J Neurol Neurosurg Psychiatry. 2001;71:215–9.
Moro E, et al. The impact on Parkinson’s disease of electrical parameter settings in STN stimulation. Neurology. 2002;59:706–13.
Dayal V, et al. Subthalamic nucleus deep brain stimulation in Parkinson’s disease: the effect of varying stimulation parameters. J Parkinsons Dis. 2017;7:235–45.
Limousin P, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 1995;345:91–5.
Timmerman L, et al. Ten hertz stimulation of the subthalamic nucleus deteriorates motor symptoms in Parkinson’s disease. Mov Disord. 2004;19:1328–33.
Limousin P, et al. Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord. 1996;11:231–5.
McIntyre C, et al. Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J Neurophysiol. 2004;91:1457–69.
Ranck J. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 1975;98:417–40.
Krack P, et al. Postoperative management of subthalamic nucleus stimulation for Parkinson’s disease. Mov Disord. 2002;17(Suppl. 3):S188–97.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gupta, F., Agrawal, P. (2019). Optimizing Deep Brain Stimulation Programming in Parkinson’s Disease. In: Goodman, R. (eds) Surgery for Parkinson's Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-23693-3_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-23693-3_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23692-6
Online ISBN: 978-3-319-23693-3
eBook Packages: MedicineMedicine (R0)